Olema Pharmaceuticals director sells shares worth $147,955 By Investing.com
SAN FRANCISCO—Harmon Cyrus, a director at Olema Prescription drugs, Inc. (NASDAQ:OLMA), a $493.56 million market cap biotech firm, lately executed ...
SAN FRANCISCO—Harmon Cyrus, a director at Olema Prescription drugs, Inc. (NASDAQ:OLMA), a $493.56 million market cap biotech firm, lately executed ...
Thomas Trutschel | Photothek | Getty PhotosThe board of Acurx Prescribed drugs on Wednesday permitted the acquisition of as much ...
Catalyst Prescribed drugs, Inc. (NASDAQ:CPRX) Q3 2024 Earnings Convention Name November 7, 2024 8:30 AM ET Firm Contributors Richard Daly ...
Sunday 29 June 2025 10:42 am Share Fb Share on Fb X Share on Twitter LinkedIn Share on LinkedIn WhatsApp...
Copyright © 2024 PWC.
Copyright © 2024 PWC.